MicroPort® EP Attends 5th Longcheng Cardiology Conference

Taiyuan, China - Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort® EP") recently attended the 5th Longcheng Cardiology Conference held from September 2 to September 4 in Taiyuan of Shanxi Province. The conference offered the latest technology, concept and idea in the cardiovascular field with academic lectures and procedure broadcasting, and invited domestic and international experts to deeply investigate into the current status of cardiovascular diseases.
During the conference, MicroPort® EP was the only company to exhibit equipment, with its Columbus® 3D EP Navigation System ("Columbus®") and FireMagic® Irrigated Ablation Catheter ("FireMagic®") on display. It was the first appearance of the domestically made, magnetic positioning 3D navigation system in Shanxi Province. Many attendees were attracted to visit our booth and inquire for product information. Several experts, including Prof. Xuewen Li, Chairman of the conference and Director of Cardiovascular Department of Shanxi Dayi Hospital of Shanxi Academy of Medical Sciences, also visited MicroPort® EP booth to experience the domestically made 3D navigation system for the first time with great interest, and expressed their expectation to see more domestically made electrophysiological devices to benefit the patients.
Columbus® is the first domestically developed 3D EP navigation system that features real time electromagnetic device tracking with cardiac motion compensation. It is designed for the diagnosis and treatment of complex arrhythmias. With the help of MicroPort® EP's FireMagic® that shows precise location of the catheter curve in the body, Columbus® offers vivid 3D simulation of the catheter deflectable segment and accurate geometric reconstruction of intra cardiac chambers, which provides physicians with a comprehensive solution for the radiofrequency ablation treatment of complex arrhythmias. Both Columbus® and FireMagic® have obtained approval from China Food and Drug Administration and officially entered the China market. In the future, MicroPort® EP will continue to innovate, and strive to realize the company vision of "providing a complete solution with combination of active and passive device and equipment, and becoming the industry leader in the field of cardiac electrophysiology and ablative diagnosis and treatment."